Skip to main content

Table 1 Host characteristics

From: Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients

 

ccRCC cases, n (%)

Variables

Early stagea

Late stagea

Age, mean (SD)

58.46 (9.85)

59.57 (8.45)

BMI, mean (SD)

30.70 (6.39)

30.12 (7.07)

Sex

 Male

67 (74.44)

68 (73.91)

 Female

23 (25.56)

24 (26.09)

Age

 < =60

44 (48.89)

43 (46.74)

 > 60

46 (51.11)

49 (53.26)

Smoking status

 Never

40 (44.44)

43 (46.74)

 Former

43 (47.78)

42 (45.65)

 Current

7 (7.78)

7 (7.61)

BMI

 < 30

45 (50.00)

57 (61.96)

>= 30

45 (50.00)

35 (38.04)

Hypertension

 Yes

65 (72.22)

68 (73.91)

 No

25 (27.78)

24 (26.09)

Diabetes

 Yes

19 (21.11)

17 (18.48)

 No

71 (78.89)

75 (81.52)

Tumor gradeb

 1

1

0 (0.00)

 2

43 (47.78)

9 (9.78)

 3

37 (41.11)

52 (56.52)

 4

8 (8.89)

29 (31.52)

 None

1 (1.11)

2 (2.17)

Recurrence

 Yes

17 (18.9)

74 (80.4)

 No

73 (81.1)

18 (19.6)

Death

 Yes

11 (33.3)

22 (66.7)

 No

79 (53.0)

70 (47.0)

Treatment

 Surgery-only

64 (70.33)

76 (83.52)

 Surgery-plus-chemotherapy

27 (29.67)

15 (16.48)

  1. aEarly stage indicated stage I or II disease; late stage indicated stage III disease. The staging criteria derived from NCCN guidelines 2019 v.2.0
  2. bTumor grade based on Fuhrman criteria